@Wingman68 and
@SGO
This is what I mean. The following are some of the sources I have relied on when posting (along with their qualifications). You two view them as unqualified yet have not provided the reasons you trust those you have decided are good sources.
David Wentworth, PhD, has a Doctor of Philosophy degree in virology at the University of Wisconsin-Madison, where he specialized in the study of influenza viruses. He studied coronaviruses as a postdoctoral fellow, and later as an instructor in the Department of Microbiology at the University of Colorado Health Sciences Center in Denver. Dr. Wentworth has conducted virological research since 1990 and has published 200 papers.
Dr. Wentworth was director of Viral Programs at the J. Craig Venter Institute from 2011 to 2014, where his studies focused on interspecies transmission, pathogenesis, viral evolution and vaccine development using synthetic genomic strategies. From 2002 to 2011, Dr. Wentworth was the director of the Influenza Virus and Coronavirus Pathogenesis laboratory at the Wadsworth Center, NYSDOH. He also was an assistant professor at the State University of New York-Albany, where his laboratory studied interspecies transmission of influenza viruses and coronaviruses (e.g., SARS-CoV), genomic technologies, and experimental vaccine approaches.
John Barnes, PhD, earned his Doctor of Philosophy degree in biochemistry and molecular biology from University of Georgia in Athens, Georgia (GO DAWGS!). He was a postdoctoral fellow at the Emory University Department of Human Genomics.
Terrence M. Tumpey, PhD, earned his Bachelor of Arts degree in biology from the University of Minnesota and his Doctor of Philosophy in microbiology/immunology from the University of South Alabama School of Medicine in Mobile, Alabama. He was a recipient of the American Society for Microbiology (ASM) Postdoctoral Fellowship award and conducted his postdoctoral training in CDC’s Influenza Branch. He later served the U.S. Department of Agriculture (USDA) as a Microbiologist at the Southeast Poultry Research Laboratory in Athens, Georgia. His research on pathogenesis and immunity during the last 30 years is documented in over 250 total peer-reviewed publications. In 2006, he was honored with the Lancet Award for the top scientific paper of 2005. He also received the 2006 and 2008 Charles C. Shepard awards for outstanding research papers. In 2007, Dr. Tumpey was inducted into the University of Minnesota, Duluth Academy of Science and Engineering, and he received the distinguished alumni award presented by the University of South Alabama.
Vivien G. Dugan, PhD, earned a Bachelor of Science degree in biology from Union College, a Master of Science in veterinary parasitology, and a Doctor of Philosophy in infectious diseases from the College of Veterinary Medicine, University of Georgia, where she specialized in zoonotic, tick-borne pathogens. She studied avian influenza genomics as an NIH-funded postdoctoral fellow at The Institute for Genomic Research and the Armed Forces Institute of Pathology. Dr. Dugan completed her training on influenza virology and the evolution of pandemic and avian influenza viruses, including the 1918 and 2009 H1N1 pandemic viruses, at the Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), NIH. Dr. Dugan was a program officer in the Office of Genomics and Advanced Technologies, Division of Microbiology and Infectious Diseases, NIAID, NIH. She provided leadership and scientific guidance for extramural research for controlling and preventing infectious diseases. This included functional genomics and systems biology approaches to study antimicrobial resistance, MERS and SARS coronaviruses, influenza viruses, and Ebola and Zika viruses. Dr. Dugan was an assistant professor of viral genomics at the J. Craig Venter Institute from 2010 to 2012, where she focused on influenza and vector-borne viral genomics, viral evolution and synthetic influenza vaccine development.
Robert S. Langer completed his undergraduate stidies in Chemical Engineering at Cornell University and obtained his Sc.D in Chemical Engineering at MIT. He joined MIT as Assistant Professor of Nutritional Biochemistry in 1978. Dr. Langer has received over 220 major awards. He is one of 5 living individuals to have received both the United States National Medal of Science (2006) and the United States National Medal of Technology and Innovation (2011). He also received the 2002 Charles Stark Draper Prize, considered the equivalent of the Nobel Prize for engineers, the 2008 Millennium Prize, the world’s largest technology prize, the 2012 Priestley Medal, the highest award of the American Chemical Society, the 2013 Wolf Prize in Chemistry, the 2014 Breakthrough Prize in Life Sciences and the 2014 Kyoto Prize. He is the also the only engineer to receive the Gairdner Foundation International Award.
Kathrin U. Jansen, Ph.D., served as Senior Vice President at Wyeth Pharmaceuticals and on Wyeth’s R&D Executive Committee since 2006 and was responsible for vaccine discovery, early development and clinical testing operations. Dr. Jansen spent 12 years at Merck Research Laboratories where she directed or supported a number of vaccine efforts, including Merck’s novel bacterial vaccine programs and viral vaccine programs (rotavirus, zoster and mumps, measles and rubella).
She received her doctoral degree in microbiology, biochemistry & genetics from Phillips Universitaet, Marburg, Germany, in 1984. Following completion of her formal training, she continued her postdoctoral training at Cornell University working on the structure and function of the acetylcholine receptor. She then joined the Glaxo Institute for Molecular Biology in Geneva, Switzerland, where she focused on basic studies of a receptor believed to be a drug target to treat allergies.
Dr. Jansen was appointed an Adjunct Professor at the University of Pennsylvania – School of Medicine in 2010 and has authored and co-authored over 190 publications. She is a member of the CEPI (Coalition for Epidemic Preparedness Innovations) scientific advisory committee, American Society for Microbiology and a Fellow of the Royal Society of Medicine.
Larisa Gubareva, MD, PhD, earned her Doctor of Medicine degree from the State Medical University and Doctor of Philosophy degree from the Ivanovsky Institute of Virology, Moscow, Russia. Sge completed her postdoctoral training at the Department of Virology and Molecular Biology at St. Jude’s Children’s Research Hospital in Memphis, Tennessee. Dr. Gubareva joined the faculty of the Division of Infectious Diseases and International Health, Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville, Virginia. Dr. Gubareva is a renowned expert in the field of influenza virology and antivirals. She has authored and co-authored over 160 peer-reviewed research articles, reviews and book chapters. She received Charles C. Shepard Award in 2010 and was nominated by the NCIRD for Charles C. Shepard awards in 2015 and 2016. She serves on editorial boards of four scientific journals (
Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy, Antiviral Research, and Influenza and Other Respiratory Virus Diseases).
